Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024-07 · 44 (7) · 1485-1490
DOI: 10.1161/atvbaha.124.319483 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-07. Verfasst von Sotirios Tsimikas. Beteiligte Einrichtung: University of California San Diego, La Jolla. Hauptthemen laut MEDLINE: Lipoprotein(a). Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
In fitting with the American Heart Association’s 100th anniversary of its founding and Arteriosclerosis, Thrombosis and Vascular Biology organizing a Centennial Collection to celebrate this event, lipoprotein(a) [Lp(a)] celebrates its 61(st) birthday in November 2024. There has been substantial progress in understanding the biology and pathophysiology of Lp(a) in the last 6 decades, including its discovery as a unique β-lipoprotein containing the pathognomonic apolipoprotein(a) moiety covalently bound to apolipoprotein B-100, its independent monogenetic association with cardiovascular disease and calcific aortic valve disease, its increased content of pro-atherogenic and pro-inflammatory of oxidized phospholipids relative to other lipoproteins and the development of RNA therapeutics to lower plasma Lp(a) levels. The validation or refutation of the “Lp(a) hypothesis”, namely that lowering plasma Lp(a) will lead to clinical benefit, is ongoing in 3 clinical outcomes trials. This essay reviews the discovery of Lp(a), summarizes the seminal pathophysiological findings since its discovery, discusses ongoing clinical trials with novel drugs and approaches, and provides a look ahead to unanswered questions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of California San Diego, La Jolla.
ORCID-Profile: Sotirios Tsimikas
Förderung
- NHLBI NIH HHS
Zitieren
APA
Tsimikas, S. (2024). Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(7), 1485-1490. https://doi.org/10.1161/atvbaha.124.319483
Vancouver
Tsimikas S. Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024;44(7):1485-1490. doi:10.1161/atvbaha.124.319483
BibTeX
@article{Tsimikas2024,
author = {Tsimikas, Sotirios},
title = {Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
volume = {44},
number = {7},
pages = {1485--1490},
doi = {10.1161/atvbaha.124.319483}
}
EUVIMED